Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. Its current products include Motiva, NNZ-2566 and NNZ-2591. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.
It is a well known fact that Australians and New Zealanders have a rich history of gentle ribbing, but while the great debate about who makes the better Pavlova remains unresolved, Skaffold has found some common ground where we all agree and that is adding New Zealand stocks dual listed on the ASX into Skaffold. We have added 39 requested stocks into Skaffold (Australia).